Tag: leader

BLUE ASH, Ohio, June 18, 2026 (GLOBE NEWSWIRE) -- Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today announced the relocation of Resilience’s corporate headquarters from San Diego, California to Blue Ash, Ohio, a northern suburb of Cincinnati. Resilience is a leading biomanufacturing contract and development manufacturing organization (CDMO) dedicated to broadening access to complex medicines, with a large drug product manufacturing facility in West Chester, Ohio. This move strengthens the company’s operational footprint in the state, and reinforces Ohio’s position as a growing hub for pharmaceutical and sterile manufacturing innovation.

Long to lead commercial growth as demand accelerates for flexible load management, energy optimization, and new revenue opportunities across energy-intensive industries and power suppliers

LIVERMORE, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Inertia Enterprises, the commercial fusion energy company, today announced the formation of its Science and Technology Advisory Board (STAB). The newly formed advisory board is an independent group of the world's foremost experts in fusion plasma physics, high-energy laser systems, large-scale program execution, target fabrication, and nuclear materials science. Its purpose is to provide rigorous, independent technical assessment across Inertia's physics, target, laser, and power plant development programs as the company prepares to deliver grid-scale fusion energy in the 2030s.

REYKJAVIK, ICELAND (June 18, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were offered by Alvotech. Before deducting the underwriting discounts and commissions and offering expenses, the aggregate gross proceeds to the Company were approximately $98 million.